December 21, 2017
Beyond fielding an ever-increasing number of digital health clearances, the FDA had a full plate in 2017 as it sought to revise its regulatory processes for the shifting healthcare landscape. The beginning of the year saw a new administration take the reins, and with it the nomination and appointment of a new commissioner, Dr. Scott Gottlieb. By the year’s end, the new guard already had announced...
July 6, 2017
San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use.